Performers / Professionals From Around The Globe

Jane Lebkowski

Regenerative Patch Technologies USA
USA

Jan Lukas Robertus

Imperial College London, United Kingdom
UK

Gabrielle Bradshaw

Queensland University of Technology, Australia
Australia

Richard Harbottle

German Cancer Research Center, Germany
Germany

Ian Gallicano

Georgetown University Medical Center Washington DC, USA
USA

Suzanne A Al Bustan

Kuwait University, Kuwait
Kuwait

Magnus S. Magnusson

University of Iceland, Iceland
Iceland

Ewelina Kawecka

Warsaw University of Life Sciences, Poland
Poland

Sudha Bansode

Shankarrao Mohite College, India
India

Huanxiang Zhang

Medical College of Soochow University, China
China

Iman Yousefi Javan

University of Torbat Heydarieh, Iran
Iran

Khalid Shah

USA

Tracks & Key Topics

Academic Key Topics

Business Key Topics

About Conference

About Conference

In continuation to 1^stsuccessful past scientific meeting, 2^nd EuroSciCon Conference on Cell and Gene Therapy will be held on April 08-09, 2019 on Paris, France.

EuroSciCon suggests every single person to attend "Genetherapy 2019” in the midst of April 08-09, 2019 at Paris, France which merges brief keynote introductions, speaker talks, Exhibitions, Symposia, Workshops.

Genetherapy 2019 will gather world-class educators, researchers, analysts, Molecular Biologist, Gene therapists , Young Researchers working in the related fields to consider, exchange views and their experiences before an extensive worldwide social occasion of individuals. The social gathering warmly welcomes Presidents, CEO's, Delegates and present day experts from the field of Gene therapy and Public wellbeing and other pertinent organization positions to take an interest in these sessions, B2B get together and board talks. The assembly of this event will be revolving around the topic “Exploring the possibilities and breakthroughs in cell and gene therapy”.

EuroSciCon is the longest running independent life science events company with a predominantly academic client base. Our multi professional and multi-specialty approach creates a unique experience that cannot be found with a specialist society or commercially. EuroSciCon are corporate members of the following organizations: Royal Society of Biology, IBMS Company.

This global meeting gives the chance to Molecular Biologist, Gene Therapists, young researchers, specialists and analysts throughout the world to assemble and take in the most recent advances in the field of Cell and Gene Therapy and to trade innovative thoughts and encounters.

• 2 days of scientific exchange

• 100+ abstracts submitted

• 20+ scientific sessions

• 50+ worldwide professionals

• 80+ healthcare experts

Genetherapy 2019 is the yearly gathering directed with the help of the Organizing Committee Members and individuals from the Editorial Board of the supporting cell and Gene therapy related journals.

Reason to attend?

Genetherapy 2019 is relied upon to give young researchers and scientists a platform to present their revolutions in the field of Cell and Gene Therapy. This conference invites Presidents, CEO's, Delegates and present day specialists from the field of Cell and Gene Therapy and Public wellbeing and other pertinent organization positions to take an interest in this sessions, B2B get together and board talks.

About City:

Paris, the world's most popular city destination, has plenty of must-see places but make sure you spend at least a day strolling off the beaten path, as this is the only way to discover the real Paris: a lively cosmopolitan but undeniably French city.

The city is known for its cafe culture and designer boutiques along the Rue du Faubourg Saint-Honoré. Paris is the city of love, inspiration, art and fashion. It has a population of more than 2million people and is divided into 20 districts. Paris has a lot of interesting architecture and museums to offer; among them the famous tourist place to visit is the Eiffel Tower. A significant number of the acclaimed roads and city building areas structures where changed by Haussmann and Napoleon III (Charles Louis Napoleon Bonaparte). The lanes where made much wider, places and squares where fabricated and the structures totally modified. Paris has a nickname called “La Ville-Lumiere. The famous places to visit in Paris are Notre Dame Cathedral which is Roman Catholic Cathedral situated in the eastern half of the city, Louvre Museum which is located at the heart of Paris , Champs Elysees which is a Arc of Triumph, Montmartre which is a hill located at the north of Paris and its height is 130 metre, it is best known White Domed Basilica of the sacred heart at the top, Quartier Latin which is called the famous private garden located on the left bank of the seine around the Sorbonne, Disneyland Paris which is located 32 km from central Paris , it has two theme parks –Disneyland and Walt Disney studios.

Session and Tracks

Track 1: Cell Science Research

Cell Science Research examines cells – their physiological properties, their structure, the organelles they contain, interchanges with their condition, their life cycle, division, end and cell work.

Track 2: Cell & Gene Therapy

Quality treatment is described as a plan of approaches that modify the announcement of a man's characteristics or repair bizarre characteristics. Each system incorporates the association of a specific nucleic destructive (DNA or RNA). Nucleic acids are frequently not taken up by cells, henceforth exceptional transporters; implied 'vectors' are required. Vectors can be of either mainstream or non-viral nature however Cell treatment is portrayed as the association of living whole cells into the patient for the treatment of a disease. The start of the cells can be from a comparable individual (autologous source) or from another individual (allogeneic source). Cells can be gotten from undifferentiated life forms, for instance, bone marrow or induced pluripotent central microorganisms (iPSCs), rethought from skin fibroblasts or adipocytes. Youthful microorganisms are associated with respect to bone marrow transplantation particularly. Distinctive methods incorporate the utilization of basically create cells, isolated in vitro (in a dish) from essential microorganisms.

Track 3: Regenerative Medicine

Regenerative Medicine implies a social affair of biomedical approaches to manage investigate and clinical applications which are away to supplant or "recouping" human cells, tissues or organs to restore or set up conventional limits which were vexed on account of afflictions. The field of Regenerative medication has pulled in much thought as it holds the assurance of recuperating hurt tissues and organs in the body by supplanting hurt tissue or by strengthening the body's own repair segments to patch hurt tissues or organs. It in like manner may enable analysts to create tissues and organs in the lab and safely install them inside the body. Regenerative courses of action subsequently can be a dynamic progress in the field of therapeutic administrations.

Track 4: Immunotherapy

Due to rapidly pushing field of tumor immunology as of late, there has been age of a couple of new procedures for treating development called Immunotherapies. Immunotherapy is a sort of treatment that extends the nature of safe response against tumors either by enabling the activities of specific sections of safe structure or by checking signals conveyed by illness cells that cover safe responses. A couple of sorts of immunotherapy are also called as biologic treatment or biotherapy. Late movements in development immunotherapies have given new supportive systems. These consolidate tumor-related macrophages as treatment centers in oncology, in-situ commencement of platelets with checkpoint inhibitors for post-careful development immunotherapy, safe checkpoint blockade and related endocrinopathies and some more.

Related Keyword :

Top Immunotherapy Conferences | International Genetic Immunotherapy Conferences | Top Gene Therapy Conferences

Track 5 : Genetics and stem cell biology

An undifferentiated mass of cell in a multicellular animal which is prepared for offering rise to uncertain number of cells of a comparable sort, and from which certain diverse sorts of cell rise by detachment. Undifferentiated life forms can isolate into specific cell creates. The two describing characteristics of an undifferentiated cell are endless self-restoration and the ability to isolate into a specific adult. There are two critical classes of youthful microorganisms: pluripotent that can end up being any cell in the adult body, and multipotent that is kept to transforming into a more limited masses of cells.

Track 6: Epigenetics

The examination of changes in living creatures caused by alteration of quality verbalization instead of adjustment of the inherited code itself. Epigenetics are unfaltering heritable characteristics that can't be cleared up by changes in DNA progression.

Track 7: Human Genomics

The human genome is the total arrangement of nucleic corrosive groupings for people, encoded as DNA inside the 23 chromosome combines in cell cores and in a little DNA particle found inside individual mitochondria. Human genomes incorporate both protein-coding DNA genes and noncoding DNA

Related Keyword:

International human genomics conference | Top Genomic Conferences | Genome Sequencing Conferences

Track 8: Next Generation Sequencing

Deoxyribonucleic destructive, for the most part known as DNA, contains the outlines of life. Inside its structures are the codes required for the party of proteins and non-coding RNA – these sub-nuclear mechanical assemblies impact all the natural systems that make and care forever. By understanding the game plan of DNA, examiners have had the ability to outline the structure and limit of proteins and what's more RNA and have gotten a cognizance of the essential purposes behind ailment. Front line Sequencing (NGS) is an able stage that has enabled the sequencing of thousands to countless iotas in the meantime. This compelling device is evolving fields, for instance, redid medicine, inherited infections, and clinical diagnostics by offering a high throughput elective with the capacity to progression various individuals meanwhile.

Track 9: Gene Editing and CRISPR Based Technologies

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Technology is a champion among the most fit yet clear mechanical assembly for genome changing. It urges and empowers investigators to easily change DNA groupings and modify quality limits. It has various potential applications that join helping innate disseminates, treating and keeping the spread of diseases and improving yields. CRISPR broadly used as CRISPR-Cas9 where CRISPRs are particular stretches out of DNA and Cas9 is the protein which is an aggravate that exhibitions like a few nuclear scissors, fit for cutting DNA strands. The assurance of CRISPR advancement anyway raises moral stresses as it isn't 100% compelling. Regardless, the progression of CRISPR-Cas9 has disturbed the designed science industry these days, being a clear and great quality changing device.

Track 10: Proteomics

Proteomics is the broad scale examination of proteomes. A proteome is a course of arrangement of proteins made in a living being, structure, or regular setting. We may imply, for instance, the proteome of a creature composes (for example, Homo sapiens) or an organ (for example, the liver). The proteome isn't relentless; it fluctuates from cell to cell and changes after some time. To some degree, the proteome reflects the key transcriptome. Regardless, protein activity (regularly reviewed by the reaction rate of the systems in which the protein is incorporated) is similarly changed by various components despite the verbalization level of the appropriate quality.

Track 11: Viral Gene Therapy

Customary strategies for quality treatment fuse transfection. It twisted up clearly inefficient and confined fundamentally in view of movement of value into right now duplicating cells invitro. Quality treatment utilizes the transport of DNA into cells by techniques for vectors, for instance, natural nanoparticles or viral vectors and non-viral systems. The Several sorts of contaminations vectors used as a piece of value treatment are retrovirus, adenovirus, disease adeno-related and herpes simplex contamination. While other recombinant viral vector structures have been delivered, retroviral vectors remain the most surely understood vector system for quality treatment traditions and most prominent application on account of their certain significance as the essential vectors made for compelling quality treatment application and the soonest phases of the field of value treatment.

Track 12: Cell Therapy of Cardiovascular Disorders

Cardiovascular contaminations have transformed into a growing clinical issue all around. the other test in the treatment of the cardiovascular disease is cell transplantation or cell cardiomyoplasty. Exceptional ischaemic harm and relentless cardiomyopathies incite unending loss of cardiovascular tissue and in the end heart disillusionment. Force medications wide mean to tighten the over the top changes that happen when harm and to cut back shot segments of vas diseases. Regardless, they don't improve the patient's close to home fulfillment or the figure more than coordinate. Unmistakable sorts of undifferentiated living beings have been used for primary microorganism treatment.

Track 13: Regulatory and Safety Aspects of Cell and Gene Therapy

Cell treatment things require a combination of prosperity examinations. Comparable living being and quality things are heterogeneous substances. There are a few zones that particularly ought to be tended to as it is extremely not the same as that of pharmaceuticals. These range from making group consistency, thing soundness to thing prosperity, quality and sufficiency through pre-clinical, clinical examinations and displaying endorsement. This review plots the present headings/administers in US, EU, India, and the related challenges in making SCBP with highlight on clinical point.

Track 14: Markets & Future Prospects for Cell & Gene Therapy

The immense number of associations related with cell treatment has extended development incredibly in the midst of the past couple of years. More than 500 associations have been recognized to be locked in with cell treatment and 305 of these are profiled 291 co-tasks. Of these associations, 170 are related with fundamental microorganisms. The Profiles of 72 academic establishments in the US related with cell treatment close by their business facilitated efforts. Allogeneic development with in excess of 350 clinical preliminaries is prepared to order the commercialization of cell medicines in publicize. Advance R&D in cell and quality treatment is depended upon to bloom given the normally based purposes of intrigue.

Track 15: Gene therapy for Diseases

Gene therapy is the addition of particular genes at some particular locales into a person's cells or tissues to treat an illness, in which the inadequate or non-working quality is then supplanted with the working quality.

Track 16: Stem Cell therapy

Stem Cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Recent studies are going on for the treatment of Spinal cord injury as well. Thus, Stem cell therapy has a great scope in future as well.

Track 17: Gene Editing

Gene Editing is where the defective gene is being expelled or supplanted from the genome, in order to change the imperfect type of quality to a working structure. Different methods, for example, gene substitution, gene knock out, gene knock down are utilized for this reason. Additionally, site coordinated mutagenesis has been broadly utilized for gene altering purposes.

Track 18: Vectors Used in Gene Therapy

Different vectors are being utilized in the gene therapy, as to convey the gene of interest in the target cell. The DNA is specifically focused to the cell. Viral vectors are for the most part utilized for focusing on the particular DNA to the target cell. Cases of viral vectors incorporate, Retroviruses, Adenoviruses, Herpes Simplex viruses Apart from viral vectors, we additionally have non-viral vectors including physical and substance strategies for targeting.

Track 19 Cell Biology

Cell biology is the investigation of cell and how the cell capacities. Cell consist of numerous organelles that perform particular capacities and assume an imperative part in the development and growth of an organism. Cells are of 2 composes Prokaryotic Cell and Eukaryotic Cell. Case of a Prokaryotic Cell incorporates, Bacteria, then again Animal Cell and Plant Cell are portrayed as Eukaryotic Cells

Related Keywords:

Stem Cell Biology Conferences | Genetic Cell Biology Conferences | Top Stem Cell Biology Conferences | International Stem Cell Therapy Conferences

Track 20: Ethical issues related to Gene therapy

Picking up part enthusiasm among the scientists, Gene therapy still has an excessive number of moral issues. Some of which incorporate the utilization of foreign gene insertion into the nonfunctional gene. Additionally utilizing the animal models for the investigation of gene therapy and cell therapy tests has made an excessive number of moral issues among individuals.

Related Keywords:

Gene therapy Conferences | Cell and Gene Therapy Conferences | International Gene therapy Conferences | Top Genetic research conferences

Track 21: Gene therapy in tissue engineering

Gene Therapy have a great deal of later and future progressions, likewise has a high extension in tissue engineering too. Tissue Engineering is a logical field and furthermore characterized as understanding the standards of tissue and its development by substitution of deficient tissue for clinical utilize. Tissue engineering deals about the investigation of mix of cells, designing, materials techniques, physicochemical and biochemical components to supplant or enhance natural tissues. Tissue Engineering includes the utilization of Scaffolds to frame practical tissues and organs, which can be embedded once again into the donor host with the utilization of many designing and materials strategies alongside some physicochemical components. It is identified with in excess of one branch which applies designing information and life science ideas towards the advancement of natural substitutes which can enhance or re-establish physiological attributes of organ.

Track 22: Genomic Medicine

Genomic medicine is an ongoing and rising field. It is utilized in treatment of particular issue. Genomic Medicine includes utilizing genomic data around a person as a component of their clinical care (e.g., for diagnostic or therapeutic decision making) and the wellbeing results and policy implifications of that clinical use." As of now, genomic medicine is having an impact in the fields of oncology, pharmacology, exceptional and unfamiliar infections, and powerful ailment

Track 23: Cell culture process

Cell culture technique is the procedure of cell development under research facility conditions in a controlled way, where all the basic development necessities are being controlled in a particular sum. A portion of these components incorporate Oxygen prerequisites, Carbon dioxide necessities, Light necessities and some more. Cell cultures are of different kinds, for example, microbial cultures, Viral cultures, Animal cell culturing.

Track 24:Cellular Pathology

Pathology, is the investigation of disease. A few sicknesses speak to hinderance in the capacity of a cell to create and work regularly, and at times infection may result when outer stimuli deliver a sudden change in the cell's condition that make it unthinkable for the cell to look after homeostasis.

Track 25: Cell damage and adaptation

Cell damage can happen as a result of cell harm, and cell harm can furthermore happen as a result of advancement in cell's condition on account of outside or inside stimuli. Exactly when a cell couldn't change and repair itself to this advancing condition, cell destruction happens. Cell end is of 2 forms Apoptosis ( Programmed Cell passing) and Necrosis (Cell destruction in view of harm).

Learn More

USA Conferences

International Conference on Viral Vaccines and Gene Therapy, Aug 08-09, 2019, New York | International Conference on Gene Therapy, DNA Vaccination and Immunotherapy , Oct 08-09, 2019, New York | International Conference on Gene Therapy, DNA Vaccination and Immunotherapy , Oct 08-09, 2018 | International Conference on Viral Vectors, Gene Therapy and Vaccines, Jun 06-07, 2019 |International Conference on Viral Vectors, Gene Therapy and Vaccines , Nov 26-27, 2018 |International Conference on Veterinary Industrial Pharmacology and Gene Therapy , Jun 04-05, 2019 |International Conference on Viral Vaccines and Viral Gene Therapy Vectors , Sep 26-27, 2019

Europe Conferences

Asia Conferences

International Conference on Cell and Gene Therapy , Mar 29-30, 2020 | International Conference on Advanced Gene Therapy Technologies , Jan 30-31, 2019 |International Conference on Medical Biotechnology and Gene Therapy , May 02-03, 2019|International Conference on Molecular Biotechnology, Molecular Diagnostics and Gene Therapy , Jun 20-21, 2019|International Conference on Veterinary Pharmacology and Gene Therapy, Jan 07-08, 2019|International Conference on Molecular Biotechnology, Diagnostics and Gene Therapy, Jun 20-21, 2019

Journals of Cell and Gene therapy:

Gene Technology Hereditary Genetics : Current Research || Human Genetics & Embryology || Insights in Stem Cells || Journal of Aging Science || Journal of Cell Science & Therapy || Journal of Clinical & Medical Genomics || Journal of Clinical Developmental Biology || Journal of Clinical Epigenetics Journal of Cytology & Histology || Journal of Down Syndrome & Chromosome Abnormalities || Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology Journal of Genetic Disorders || Journal of Genetic Disorders & Genetic Reports || Advancements in Genetic Engineering || Advances in Molecular Diagnostics || Cell & Developmental Biology || Cell Biology: Research & Therapy || Hybrid Cellular & Molecular Medicine || Cellular and Molecular Biology Cloning & Transgenesis || Epigenetics Research || Fungal Genomics & Biology|| Hybrid Journal of Genetic Syndromes & Gene Therapy || Journal of European Biotechnology Thematic Network Association || Journal of Genetics and DNA Research || Journal of Genetics and Genomes || Journal of Molecular and Genetic Medicine || Journal of Molecular Biology and Biotechnology || Journal of Molecular Biomarkers & Diagnosis || Journal of Molecular Imaging & Dynamics || Journal of Plant Genetics and Breeding || Journal of Stem Cell Research & Therapy || Journal of Tissue Science & Engineering Molecular Biology

Cell and Gene therapy Universities in USA:

University of California--San Francisco University of Washington | Johns Hopkins University | Yale University | University of California--San Diego | University of Pennsylvania | Washington University in St. Louis | University of California, Berkeley | University of Michigan Medical Center, Ann Arbor| University of Iowa, Iowa City Harvard University |Cell and Gene therapy conferences Massachusetts Institute of Technology | Cornell University || University of Albama | University of Michigan Medical Center, Ann Arbor |Minnesota University| University of Florida, Gainesville

Cell and Gene therapy universities in europe:

Cell and Gene therapy universities in Asia:

Cell and Genetherapy Societies in USA:

American Society of Human Genetics || Genetic inheritance and evolution Genetic determinism in science and society || Frontiers in epigenetic chemical biology || Maternal Nutrition and Epigenetics - American Society for Nutrition |Genetics Society of America || Clinical Genetics Society || Cancer Genetics society || American Genetic Association

Cell and Genetherapy Societies in EUROPE

European Society of Gene and Cell Therapy || Clinical Genetics || Behaviour Genetics Association| International Behavioural and Neural Genetics Society || DNA methylation and epigenetics || Estonian Society of Human GeneticsEuropean Society of Human Genetics || The Genetics Society || Epigenetics, society, and bio-objects || Cancer Genetics

Cell and Genetherapy Societies in ASIA

Medical genetics || Asia Pacific Society of Human Genetics || Human Genetics Society of Australasia Epigenetics in Society - Scholarship at U Windsor || Cancer Genetics Society || UICC || Trends in Recent Research of Epigenetics || Professionals Society of Genetic Counsellors in Asia

Job opportunities for Cell and Gene therapy in Usa

Research Geneticist Plants Research Associate || Director, Molecular Genetics & Cytogenetics or Biochemical Genetics || Genetics Counsellor || Research Associate I - Human Molecular Genetics || Research Fellow - Statistical Genetics || Human Genetics - Research Assistant III (Stottmann Lab) || Post-Doctoral Scientist - Human Genetics || Genetic Counsellor-Genetics Clinic || Corn Specialist || Clinical Genetics Counsellor|Statistical Geneticist || Research Geneticist (Plants) Research Associate || Crop Scientist/Geneticist || Research Geneticist Plants || Research Geneticist Plants (Postdoctoral Research Associate) || Clinical Geneticist || Director of Statistical Genetics || Pediatric Geneticist - Assistant/Associate Professor || Genetic Counsellor - Medical Genetics

Job opportunities for Cell and Gene therapy in Europe

Postdoc and PhD positions in archaeogenomics, population genetics, bioarchaeology, and archaeologic || Application Scientist - Genetics/Molecular - Cambridge, UK || Staff Scientist - Mouse Genome Engineering || Senior Scientist, Computational and Statistical Genetics || Post-Doctoral Research Fellow, Statistical Genetics || Clinical Genetics Technologist || Senior Scientist, Genetics Research || Wanted Molecular and Genetics Biology Graduates || Genomics Project Manager || Part-time Research Technician - Cell Biology and Genetics Senior Bioinformatician - Genomics England || Senior Medical Advisor, Genetic Diseases - National Scope || Certified Genetic Counsellor San Francisco Perinatal| Professor, Molecular and Cell Biology and Chief Scientific Director, Innovative Genomics Institute || Clinical Genetics Supervisor || Sr. Manager of Cytogenetics || Scientist - Genome Analysis Unit (Computational Biology) || Senior Scientist, Genetics Research || PhD Position - Genetic and Epigenetic Control of Mouse Organ Development ||

Job opportunities for Cell and Gene therapy in Asia

Faculty Search for Zheizhang University || Job Opening in China Pharmaceutical University: Professor and Dean, tenured || Xinyu University | Full Professor in Plant Evolutionary Genomics and Development || Editing Technology Developments in molecular biology and In Vitro Biology || Faculty Positions at Westlake University || Full Professor in Plant Evolutionary Genomics and Development |

Market Analysis

Gene Therapy Market Overview:

Genes are made from DNA that contains basic information for making proteins that are basic for the human body to work in a perfect world. Some Gene mutations result in these proteins not being made adequately and can incite genetic turmoil. Gene therapy works by repairing, checking, or supplanting futile characteristics that reason contamination with the purpose of re-establishing standard limit. gene Therapy is an engaging region for cure change based on the way that with the right target and approach, it can address the primary driver of a genuine ailment. For particular issue where known innate changes incite deficient or non-valuable protein age, quality treatment can settle the shrouded defect and give an approach to convey the helpful protein. The overall quality treatment grandstand was regarded at $584 million out of 2016, and is assessed to reach $4,402 million by 2023, enrolling a CAGR of 33.3% from 2017 to 2023.

The extension in financing for R&D practices identifying with Gene therapy and addition in care concerning Gene therapy are the principle contemplations that drive the market advancement. Likewise, augment in government reinforce, moral affirmation of value treatment for tumor treatment, and rise in prevalence of harm can fuel the improvement of the quality treatment promote. Regardless, stunning cost related with the treatment and unwanted resistant responses are depended upon to hamper the market advancement.

Vector Segment Review Type

Based on vector compose, it is arranged into viral vector and non-viral vector. Among the vector compose, viral vector is the biggest supporter toward the market development. Non-viral vector is foreseen to be a lucrative market because of the mechanical headway of these vectors with positive outcomes for these treatments amid the preclinical and clinical preliminaries for the treatment of different maladies

Application Segment Review

Global Gene Therapy Market: Key Geographic Segment

In view of district, the gene therapy showcase is separated into North America, Europe, Asia-Pacific, and LAMEA. North America represented the biggest piece of the overall industry in the quality treatment advertise in 2016, and is relied upon to hold its strength all through the estimate time frame

The key players working in the worldwide Gene therapy showcase incorporate Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp.

Other unmistakable players in the esteem chain incorporate Amgen, Epeius Biotechnologies, Abeona Therapeutics, Sanofi, UniQure, Juno Therapeutics, Adaptimmune, Celgene, and Advantagene

The key players operating in the global gene therapy market include Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp.

Other prominent players in the value chain include Amgen, Epeius Biotechnologies, Abeona Therapeutics, Sanofi, UniQure, Juno Therapeutics, Adaptimmune, Celgene, and Advantagene.

Key Benefits

This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to type, method, technology, end user, and region.
In-depth analysis based on geography assists in understanding the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Gene Therapy Market Key Segments:

By Vector Type

Viral vector
- Retroviruses
- Lentiviruses
- Adenoviruses
- Adeno Associated Virus
- Herpes Simplex Virus
- Poxvirus
- Vaccinia Virus
- Others
Non-viral vector
Naked/Plasmid Vectors
Gene Gun
Electroporation
Lipofection
Others

By Gene Type

Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Growth factors
Receptors
Others

By Application

Oncological Disorders
Rare Diseases
Cardiovascular Diseases
Neurological Disorders
Infectious disease
Other Diseases

By Region

North America
- U.S.
- Canada
- Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Japan
China
India
South Korea
Rest of Asia-Pacific
Brazil
Republic of South Africa
Rest of LAMEA
Asia-Pacific
LAMEA

Past Conference Report (Cell and Gene Therapy 2018)

The International Conference & Expo on Cell and gene therapy (Genetherapy 2018) hosted by Euroscicon took place at Hyatt Place, Amsterdam, Netherlands during August 20-21, 2018. It was organized by Euroscicon and generous response was received from the Editorial Board Members of Euroscicon Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2018 from Euroscicon. The program witnessed thought provoking keynote and plenary presentations from experts in the field of Gene Therapy, highlighting the theme, "Advancements in Cell and gene therapy:Making a dead cell work".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Cell Science Research
Next Generation Sequencing
Stem Cell therapy
Immunotherapy
Regenerative Medicine
Gene Mutation and cloning
Human Genetics & Genetics Disorders

The highlights of the meeting were form the eminent keynote lectures from

Richard Harbottle, German Cancer Research Centre, Germany
Jan Lukas Robertus, Imperial College London, UK
Magnus Magnusson, University of Iceland, Iceland

Cell and Genetherapy 2018 played an important role in promoting multidisciplinary interactions between science and technology to enhance research in Cell and Gene Therapy. The program covered current and emerging research innovations in the field of Gene Therapy.

We would specially thank the Moderator of the event Dr. Ewelina Kawecka, Warsaw University of Life Sciences for his contribution for the conference.Euroscicon would like to announce the commencement of "2nd Euroscicon Conference on Cell and Gene Therapy " during April 08-09, 2019, Paris, France

Let us meet again @ Genetherapy 2019